Repligen (RGEN) Net Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.30% |
| Dec 31, 2025 | -26.01% |
| Sep 30, 2025 | 42.36% |
| Jun 30, 2025 | -7.92% |
| Mar 31, 2025 | -65.84% |
| Dec 31, 2024 | -34.03% |
| Sep 30, 2024 | -15.82% |
| Jun 30, 2024 | 7.26% |
| Mar 31, 2024 | 35.45% |
| Dec 31, 2023 | 156.70% |
| Sep 30, 2023 | 12.60% |
| Jun 30, 2023 | 84.25% |
| Mar 31, 2023 | -90.36% |
| Dec 31, 2022 | -44.48% |
| Sep 30, 2022 | -23.57% |
| Jun 30, 2022 | 9.31% |
| Mar 31, 2022 | -35.00% |
| Dec 31, 2021 | 17.97% |
| Sep 30, 2021 | -49.72% |
| Jun 30, 2021 | -29.67% |
| Mar 31, 2021 | 18.51% |
| Dec 31, 2020 | 91.96% |
| Sep 30, 2020 | -26.45% |
| Jun 30, 2020 | 15.18% |
| Mar 31, 2020 | 40.78% |
| Dec 31, 2019 | 50.88% |
| Sep 30, 2019 | 136.88% |
| Jun 30, 2019 | 27.69% |
| Mar 31, 2019 | -8.69% |
| Dec 31, 2018 | 19.88% |
| Sep 30, 2018 | 30.50% |
| Jun 30, 2018 | -14.10% |
| Mar 31, 2018 | 21.84% |
| Dec 31, 2017 | 5.49% |
| Sep 30, 2017 | 54.28% |
| Sep 30, 2016 | -86.86% |
| Jun 30, 2016 | 81.85% |
| Mar 31, 2016 | -20.29% |
| Dec 31, 2015 | 25.48% |
| Sep 30, 2015 | 4.34% |
| Jun 30, 2015 | 31.22% |